SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-080893
Filing Date
2024-03-28
Accepted
2024-03-28 17:25:36
Documents
7
Effectiveness Date
2024-03-28

Document Format Files

Seq Description Document Type Size
1 S-8 d60781ds8.htm S-8 61501
2 EX-5.1 d60781dex51.htm EX-5.1 7557
3 EX-10.2 d60781dex102.htm EX-10.2 103218
4 EX-10.3 d60781dex103.htm EX-10.3 85663
5 EX-23.1 d60781dex231.htm EX-23.1 1285
6 EX-FILING FEES d60781dexfilingfees.htm EX-FILING FEES 28187
7 GRAPHIC g60781g0328083502139.jpg GRAPHIC 2373
  Complete submission text file 0001193125-24-080893.txt   291906
Mailing Address 9880 CAMPUS POINT DRIVE SUITE 120 SAN DIEGO CA 92121
Business Address 9880 CAMPUS POINT DRIVE SUITE 120 SAN DIEGO CA 92121 (858) 766-9912
Boundless Bio, Inc. (Filer) CIK: 0001782303 (see all company filings)

IRS No.: 830751369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-278354 | Film No.: 24800586
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)